Suppr超能文献

原发性甲状旁腺功能亢进的术前影像学应用。

Use of Preoperative Imaging in Primary Hyperparathyroidism.

机构信息

Department of Endocrinology, Diabetes & Metabolism, Cleveland Clinic Foundation, Cleveland, OH.

Department of Endocrine Surgery, Cleveland Clinic Foundation, Cleveland, OH.

出版信息

J Clin Endocrinol Metab. 2021 Jan 1;106(1):e328-e337. doi: 10.1210/clinem/dgaa779.

Abstract

CONTEXT

Preoperative imaging is performed routinely to guide surgical management in primary hyperparathyroidism, but the optimal imaging modalities are debated.

OBJECTIVE

Our objectives were to evaluate which imaging modalities are associated with improved cure rate and higher concordance rates with intraoperative findings. A secondary aim was to determine whether additive imaging is associated with higher cure rate.

DESIGN, SETTING, AND PATIENTS: This is a retrospective cohort review of 1485 adult patients during a 14-year period (2004-2017) at an academic tertiary referral center that presented for initial parathyroidectomy for de novo primary hyperparathyroidism.

MAIN OUTCOME MEASURES

Surgical cure rate, concordance of imaging with operative findings, and imaging performance.

RESULTS

The overall cure rate was 94.1% (95% confidence interval, 0.93-0.95). Cure rate was significantly improved if sestamibi/single-photon emission computed tomography (SPECT) was concordant with operative findings (95.9% vs. 92.5%, P = 0.010). Adding a third imaging modality did not improve cure rate (1 imaging type 91.8% vs. 2 imaging types 94.4% vs. 3 imaging types 87.2%, P = 0.59). Despite having a low number of cases (n = 28), 4-dimensional (4D) CT scan outperformed (higher sensitivity, specificity, positive predictive value, negative predictive value) all imaging modalities in multiglandular disease and double adenomas, and sestamibi/SPECT in single adenomas.

CONCLUSIONS

Preoperative ultrasound combined with sestamibi/SPECT were associated with the highest cure and concordance rates. If pathology was not found on ultrasound and sestamibi/SPECT, additional imaging did not improve the cure rate or concordance. 4D CT scan outperformed all imaging modalities in multiglandular disease and double adenomas, and sestamibi/SPECT in single adenomas, but these findings were underpowered.

摘要

背景

术前影像学检查常规用于指导原发性甲状旁腺功能亢进的手术治疗,但最佳影像学检查方法仍存在争议。

目的

本研究旨在评估哪些影像学检查方法与提高治愈率和更高的与术中发现的一致性相关。次要目的是确定是否附加影像学检查与更高的治愈率相关。

设计、地点和患者:这是一项回顾性队列研究,纳入了 14 年间(2004-2017 年)在一家学术性三级转诊中心接受初次甲状旁腺切除术治疗新发原发性甲状旁腺功能亢进的 1485 例成年患者。

主要观察指标

手术治愈率、影像学检查与手术结果的一致性以及影像学检查的表现。

结果

总体治愈率为 94.1%(95%置信区间,0.93-0.95)。如果甲状旁腺闪烁扫描/单光子发射计算机断层扫描(SPECT)与手术结果一致,则治愈率显著提高(95.9%比 92.5%,P=0.010)。增加第三种影像学检查方法并未提高治愈率(1 种影像学检查类型为 91.8%,2 种影像学检查类型为 94.4%,3 种影像学检查类型为 87.2%,P=0.59)。尽管存在少数病例(n=28),4 维(4D)CT 扫描在多腺体疾病和双腺瘤中表现优于(更高的敏感性、特异性、阳性预测值、阴性预测值)所有其他影像学检查方法,在单发腺瘤中表现优于甲状旁腺闪烁扫描/SPECT。

结论

术前超声联合甲状旁腺闪烁扫描/SPECT 与最高的治愈率和一致性相关。如果超声和甲状旁腺闪烁扫描/SPECT 未发现病变,额外的影像学检查并不能提高治愈率或一致性。4D CT 扫描在多腺体疾病和双腺瘤中优于所有影像学检查方法,在单发腺瘤中优于甲状旁腺闪烁扫描/SPECT,但这些发现的效力不足。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验